カテゴリー： Market Monitor Global, 世界, 医療/バイオ

MSD医薬品の世界市場見通し2023年-2029年

◆英語タイトル：MSD Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5780）

◆商品コード：MMG23JU5780
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥481,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥625,300	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥721,500	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global MSD Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのMSD医薬品市場規模と予測を収録しています。・世界のMSD医薬品市場：売上、2018年-2023年、2024年-2029年
・世界のMSD医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のMSD医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

MSD医薬品のグローバル主要企業は、AbbVie、 Amgen、 Johnson & Johnson、 Roche、 Pfizer Inc、 Eli Lillyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、MSD医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のMSD医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界のMSD医薬品市場：タイプ別市場シェア、2022年
・OTC、処方薬

世界のMSD医薬品市場：用途別、2018年-2023年、2024年-2029年
世界のMSD医薬品市場：用途別市場シェア、2022年
・病院、小売薬局

世界のMSD医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界のMSD医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるMSD医薬品のグローバル売上、2018年-2023年
・主要企業におけるMSD医薬品のグローバル売上シェア、2022年
・主要企業におけるMSD医薬品のグローバル販売量、2018年-2023年
・主要企業におけるMSD医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AbbVie、 Amgen、 Johnson & Johnson、 Roche、 Pfizer Inc、 Eli Lilly

*************************************************************

・調査・分析レポートの概要
MSD医薬品市場の定義
市場セグメント
世界のMSD医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のMSD医薬品市場規模
世界のMSD医薬品市場規模：2022年 VS 2029年
世界のMSD医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのMSD医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のMSD医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、処方薬
MSD医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局
MSD医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別MSD医薬品市場規模 2022年と2029年
地域別MSD医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie、 Amgen、 Johnson & Johnson、 Roche、 Pfizer Inc、 Eli Lilly
...

Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body’s movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon
This report aims to provide a comprehensive presentation of the global market for MSD Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MSD Drugs. This report contains market size and forecasts of MSD Drugs in global, including the following market information:
Global MSD Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global MSD Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five MSD Drugs companies in 2022 (%)
The global MSD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of MSD Drugs include AbbVie, Amgen, Johnson & Johnson, Roche, Pfizer Inc and Eli Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the MSD Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global MSD Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global MSD Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global MSD Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global MSD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Global MSD Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global MSD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies MSD Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies MSD Drugs revenues share in global market, 2022 (%)
Key companies MSD Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies MSD Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of MSD Drugs, market overview.
Chapter 2: Global MSD Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of MSD Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of MSD Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global MSD Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 MSD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global MSD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global MSD Drugs Overall Market Size
2.1 Global MSD Drugs Market Size: 2022 VS 2029
2.2 Global MSD Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global MSD Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top MSD Drugs Players in Global Market
3.2 Top Global MSD Drugs Companies Ranked by Revenue
3.3 Global MSD Drugs Revenue by Companies
3.4 Global MSD Drugs Sales by Companies
3.5 Global MSD Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 MSD Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers MSD Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 MSD Drugs Players in Global Market
3.8.1 List of Global Tier 1 MSD Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 MSD Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global MSD Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global MSD Drugs Revenue & Forecasts
4.2.1 By Type – Global MSD Drugs Revenue, 2018-2023
4.2.2 By Type – Global MSD Drugs Revenue, 2024-2029
4.2.3 By Type – Global MSD Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global MSD Drugs Sales & Forecasts
4.3.1 By Type – Global MSD Drugs Sales, 2018-2023
4.3.2 By Type – Global MSD Drugs Sales, 2024-2029
4.3.3 By Type – Global MSD Drugs Sales Market Share, 2018-2029
4.4 By Type – Global MSD Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global MSD Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application – Global MSD Drugs Revenue & Forecasts
5.2.1 By Application – Global MSD Drugs Revenue, 2018-2023
5.2.2 By Application – Global MSD Drugs Revenue, 2024-2029
5.2.3 By Application – Global MSD Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global MSD Drugs Sales & Forecasts
5.3.1 By Application – Global MSD Drugs Sales, 2018-2023
5.3.2 By Application – Global MSD Drugs Sales, 2024-2029
5.3.3 By Application – Global MSD Drugs Sales Market Share, 2018-2029
5.4 By Application – Global MSD Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global MSD Drugs Market Size, 2022 & 2029
6.2 By Region – Global MSD Drugs Revenue & Forecasts
6.2.1 By Region – Global MSD Drugs Revenue, 2018-2023
6.2.2 By Region – Global MSD Drugs Revenue, 2024-2029
6.2.3 By Region – Global MSD Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global MSD Drugs Sales & Forecasts
6.3.1 By Region – Global MSD Drugs Sales, 2018-2023
6.3.2 By Region – Global MSD Drugs Sales, 2024-2029
6.3.3 By Region – Global MSD Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America MSD Drugs Revenue, 2018-2029
6.4.2 By Country – North America MSD Drugs Sales, 2018-2029
6.4.3 US MSD Drugs Market Size, 2018-2029
6.4.4 Canada MSD Drugs Market Size, 2018-2029
6.4.5 Mexico MSD Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe MSD Drugs Revenue, 2018-2029
6.5.2 By Country – Europe MSD Drugs Sales, 2018-2029
6.5.3 Germany MSD Drugs Market Size, 2018-2029
6.5.4 France MSD Drugs Market Size, 2018-2029
6.5.5 U.K. MSD Drugs Market Size, 2018-2029
6.5.6 Italy MSD Drugs Market Size, 2018-2029
6.5.7 Russia MSD Drugs Market Size, 2018-2029
6.5.8 Nordic Countries MSD Drugs Market Size, 2018-2029
6.5.9 Benelux MSD Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia MSD Drugs Revenue, 2018-2029
6.6.2 By Region – Asia MSD Drugs Sales, 2018-2029
6.6.3 China MSD Drugs Market Size, 2018-2029
6.6.4 Japan MSD Drugs Market Size, 2018-2029
6.6.5 South Korea MSD Drugs Market Size, 2018-2029
6.6.6 Southeast Asia MSD Drugs Market Size, 2018-2029
6.6.7 India MSD Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America MSD Drugs Revenue, 2018-2029
6.7.2 By Country – South America MSD Drugs Sales, 2018-2029
6.7.3 Brazil MSD Drugs Market Size, 2018-2029
6.7.4 Argentina MSD Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa MSD Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa MSD Drugs Sales, 2018-2029
6.8.3 Turkey MSD Drugs Market Size, 2018-2029
6.8.4 Israel MSD Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia MSD Drugs Market Size, 2018-2029
6.8.6 UAE MSD Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie MSD Drugs Major Product Offerings
7.1.4 AbbVie MSD Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen MSD Drugs Major Product Offerings
7.2.4 Amgen MSD Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson MSD Drugs Major Product Offerings
7.3.4 Johnson & Johnson MSD Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche MSD Drugs Major Product Offerings
7.4.4 Roche MSD Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Pfizer Inc
7.5.1 Pfizer Inc Company Summary
7.5.2 Pfizer Inc Business Overview
7.5.3 Pfizer Inc MSD Drugs Major Product Offerings
7.5.4 Pfizer Inc MSD Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Inc Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly MSD Drugs Major Product Offerings
7.6.4 Eli Lilly MSD Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
8 Global MSD Drugs Production Capacity, Analysis
8.1 Global MSD Drugs Production Capacity, 2018-2029
8.2 MSD Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global MSD Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MSD Drugs Supply Chain Analysis
10.1 MSD Drugs Industry Value Chain
10.2 MSD Drugs Upstream Market
10.3 MSD Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 MSD Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of MSD Drugs in Global Market
Table 2. Top MSD Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global MSD Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global MSD Drugs Revenue Share by Companies, 2018-2023
Table 5. Global MSD Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global MSD Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers MSD Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers MSD Drugs Product Type
Table 9. List of Global Tier 1 MSD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 MSD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global MSD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global MSD Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global MSD Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global MSD Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global MSD Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global MSD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global MSD Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global MSD Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global MSD Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global MSD Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global MSD Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global MSD Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global MSD Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global MSD Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global MSD Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America MSD Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America MSD Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America MSD Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America MSD Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe MSD Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe MSD Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe MSD Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe MSD Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia MSD Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia MSD Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia MSD Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia MSD Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America MSD Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America MSD Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America MSD Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America MSD Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa MSD Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa MSD Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa MSD Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa MSD Drugs Sales, (K Units), 2024-2029
Table 46. AbbVie Company Summary
Table 47. AbbVie MSD Drugs Product Offerings
Table 48. AbbVie MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen MSD Drugs Product Offerings
Table 52. Amgen MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson MSD Drugs Product Offerings
Table 56. Johnson & Johnson MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche MSD Drugs Product Offerings
Table 60. Roche MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Pfizer Inc Company Summary
Table 63. Pfizer Inc MSD Drugs Product Offerings
Table 64. Pfizer Inc MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Pfizer Inc Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly MSD Drugs Product Offerings
Table 68. Eli Lilly MSD Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. MSD Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global MSD Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global MSD Drugs Production by Region, 2018-2023 (K Units)
Table 73. Global MSD Drugs Production by Region, 2024-2029 (K Units)
Table 74. MSD Drugs Market Opportunities & Trends in Global Market
Table 75. MSD Drugs Market Drivers in Global Market
Table 76. MSD Drugs Market Restraints in Global Market
Table 77. MSD Drugs Raw Materials
Table 78. MSD Drugs Raw Materials Suppliers in Global Market
Table 79. Typical MSD Drugs Downstream
Table 80. MSD Drugs Downstream Clients in Global Market
Table 81. MSD Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. MSD Drugs Segment by Type in 2022
Figure 2. MSD Drugs Segment by Application in 2022
Figure 3. Global MSD Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global MSD Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global MSD Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. MSD Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by MSD Drugs Revenue in 2022
Figure 9. By Type - Global MSD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global MSD Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global MSD Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global MSD Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global MSD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global MSD Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global MSD Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global MSD Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global MSD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global MSD Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global MSD Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global MSD Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America MSD Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America MSD Drugs Sales Market Share, 2018-2029
Figure 23. US MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe MSD Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe MSD Drugs Sales Market Share, 2018-2029
Figure 28. Germany MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia MSD Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia MSD Drugs Sales Market Share, 2018-2029
Figure 37. China MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America MSD Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America MSD Drugs Sales Market Share, 2018-2029
Figure 44. Brazil MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa MSD Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa MSD Drugs Sales Market Share, 2018-2029
Figure 48. Turkey MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE MSD Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global MSD Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production MSD Drugs by Region, 2022 VS 2029
Figure 54. MSD Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ MSD医薬品の世界市場見通し2023年-2029年(MSD Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

MSD医薬品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp